This paper addresses a topic which I've long confronted - see my talk at the last TUK conference in Meriden. One cannot compare results from different labs if the methods of measurement used do not very closely agree with each other. This need has long been addressed by the Thienpont group but its implimentation by the various FT4 test manufacturers is slow or nonexistent, owing to the cost of recalibration and resubmission to regulatory authorities, with no discernible financial benefit. But if the field is to be more rationalised, this must occur, if necessary by regulatory force.
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization
October 2022
Critical Reviews in Clinical Laboratory Sciences
DOI: 10.1080/10408363.2022.2121960
Federica D'Aurizio, Jürgen Kratzsch. Damien Gruson, Luca Giovanella